Selected article for: "cardiac injury and death disease"

Author: Maino, Alessandro; Di Stasio, Enrico; Grimaldi, Maria Chiara; Cappannoli, Luigi; Rocco, Erica; Vergallo, Rocco; Biscetti, Federico; Baroni, Silvia; Urbani, Andrea; Landolfi, Raffaele; Biasucci, Luigi Marzio
Title: Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin
  • Cord-id: rqgm7yc8
  • Document date: 2021_6_19
  • ID: rqgm7yc8
    Snippet: BACKGROUND: Coronavirus disease 2019 (COVID-19) is a pandemic disease that is causing a public health emergency. Characteristics and clinical significance of myocardial injury remain unclear. METHODS: This retrospective single-center study analyzed analyzed 189 patients who received a COVID-19 diagnosis out of all 758 subjects with a high sensitive troponin I (Hs-TnI) measurement within the first 24 h of admission at the Policlinico A.Gemelli (Rome, Italy) between February 20th 2020 to April 09t
    Document: BACKGROUND: Coronavirus disease 2019 (COVID-19) is a pandemic disease that is causing a public health emergency. Characteristics and clinical significance of myocardial injury remain unclear. METHODS: This retrospective single-center study analyzed analyzed 189 patients who received a COVID-19 diagnosis out of all 758 subjects with a high sensitive troponin I (Hs-TnI) measurement within the first 24 h of admission at the Policlinico A.Gemelli (Rome, Italy) between February 20th 2020 to April 09th 2020. RESULTS: The prevalence of myocardial injury in our COVID-19 population is of 16%. The patients with cardiac injury were older, had a greater number of cardiovascular comorbidities and higher values of acute phase and inflammatory markers and leucocytes. They required more frequently hospitalization in Intensive Care Unit (10 [32.3%] vs 18 [11.4%]; p = .003) and the mortality rate was significantly higher (17 [54.8%] vs. 15 [9.5%], p < .001). Among patients in ICU, the subjects with myocardial injury showed an increase need of endotracheal intubation (8 out of 9 [88%] vs 7 out of 19[37%], p = .042). Multivariate analyses showed that hs-TnI can significantly predict the degree of COVID-19 disease, the intubation need and in-hospital mortality. CONCLUSIONS: In this study we demonstrate that hs-Tn can significantly predict disease severity, intubation need and in-hospital death. Therefore, it may be reasonable to use Hs-Tn as a clinical tool in COVID-19 population in order to triage them into different risk groups and can play a pivotal role in the detection of subjects at high risk of cardiac impairment during both the early and recovery stage.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and acute cardiac event: 1
    • absence presence and acute kidney injury: 1, 2, 3, 4, 5, 6, 7
    • absence presence and acute myocardial infarction: 1, 2
    • absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and acute presentation: 1
    • absence presence and admission diagnosis: 1, 2, 3, 4
    • absence presence and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute ards respiratory distress syndrome and administration monitoring: 1, 2
    • acute ards respiratory distress syndrome and admission diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute ards respiratory distress syndrome and admission measure: 1
    • acute ards respiratory distress syndrome and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute cardiac event and admission time: 1
    • acute coronary syndrome and admission diagnosis: 1, 2
    • acute kidney injury and admission diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute myocardial infarction and admission diagnosis: 1, 2
    • acute myocardial injury and administration monitoring: 1
    • acute phase and admission diagnosis: 1, 2
    • acute phase and admission measure: 1